Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

The intrinsic pathway of coagulation: a target for treating thromboembolic disease?

Gailani D, Renné T.

J Thromb Haemost. 2007 Jun;5(6):1106-12. Epub 2007 Feb 14. Review.

2.

Intrinsic pathway of coagulation and arterial thrombosis.

Gailani D, Renné T.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2507-13. Epub 2007 Oct 4. Review.

3.

Coagulation factor XI as a novel target for antithrombotic treatment.

Löwenberg EC, Meijers JC, Monia BP, Levi M.

J Thromb Haemost. 2010 Nov;8(11):2349-57. doi: 10.1111/j.1538-7836.2010.04031.x. Review.

4.

Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.

Schousboe I.

Biochem Pharmacol. 2008 Mar 1;75(5):1007-13. Epub 2007 Oct 7. Review.

PMID:
17996217
5.

Role of Factor XII in hemostasis and thrombosis: clinical implications.

Renné T, Gailani D.

Expert Rev Cardiovasc Ther. 2007 Jul;5(4):733-41. Review.

PMID:
17605651
6.

Novel roles for factor XII-driven plasma contact activation system.

Müller F, Renné T.

Curr Opin Hematol. 2008 Sep;15(5):516-21. doi: 10.1097/MOH.0b013e328309ec85. Review.

PMID:
18695377
7.

Roles of platelets and factor XI in the initiation of blood coagulation by thrombin.

Walsh PN.

Thromb Haemost. 2001 Jul;86(1):75-82. Review.

PMID:
11487044
8.

Inhibition of factor XIa as a new approach to anticoagulation.

Schumacher WA, Luettgen JM, Quan ML, Seiffert DA.

Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):388-92. doi: 10.1161/ATVBAHA.109.197178. Epub 2010 Feb 5. Review.

9.

Advances and dilemmas in factor XI.

Gailani D.

Curr Opin Hematol. 1994 Sep;1(5):347-53. Review.

PMID:
9371304
10.

Factor XI deficiency in animal models.

Renné T, Oschatz C, Seifert S, Müller F, Antovic J, Karlman M, Benz PM.

J Thromb Haemost. 2009 Jul;7 Suppl 1:79-83. doi: 10.1111/j.1538-7836.2009.03393.x. Review.

11.

Factor XI and XII as antithrombotic targets.

Müller F, Gailani D, Renné T.

Curr Opin Hematol. 2011 Sep;18(5):349-55. doi: 10.1097/MOH.0b013e3283497e61. Review.

12.

Gene targeting in hemostasis. factor XI.

Gailani D.

Front Biosci. 2001 Feb 1;6:D201-7. Review.

PMID:
11171549
13.

Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis.

Stavrou E, Schmaier AH.

Thromb Res. 2010 Mar;125(3):210-5. doi: 10.1016/j.thromres.2009.11.028. Review.

14.

In vivo roles of factor XII.

Renné T, Schmaier AH, Nickel KF, Blombäck M, Maas C.

Blood. 2012 Nov 22;120(22):4296-303. doi: 10.1182/blood-2012-07-292094. Epub 2012 Sep 19. Review.

15.

The hemostatic role of factor XI.

Puy C, Rigg RA, McCarty OJ.

Thromb Res. 2016 May;141 Suppl 2:S8-S11. doi: 10.1016/S0049-3848(16)30354-1. Review.

PMID:
27207433
16.

Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.

Nickel KF, Long AT, Fuchs TA, Butler LM, Renné T.

Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):13-20. doi: 10.1161/ATVBAHA.116.308595. Epub 2016 Nov 10. Review.

PMID:
27834692
17.

Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.

Mackman N, Tilley RE, Key NS.

Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1687-93. Epub 2007 Jun 7. Review.

18.

Factor XI: hemostasis, thrombosis, and antithrombosis.

He R, Chen D, He S.

Thromb Res. 2012 May;129(5):541-50. doi: 10.1016/j.thromres.2011.11.051. Epub 2011 Dec 22. Review.

PMID:
22197449
19.
20.

The many faces of the contact pathway and their role in thrombosis.

Woodruff RS, Sullenger B, Becker RC.

J Thromb Thrombolysis. 2011 Jul;32(1):9-20. doi: 10.1007/s11239-011-0578-5. Review.

PMID:
21404067

Supplemental Content

Support Center